Life ScienceCompany
Aardvark Therapeutics - ARD-301 Ownership
Who owns Aardvark Therapeutics - ARD-301?
Aardvark Therapeutics - ARD-301 is owned by SCILEX Pharmaceuticals and Sorrento Therapeutics. It was acquired on March 1, 2021.
Aardvark Therapeutics - ARD-301 Business Overview
Where is Aardvark Therapeutics - ARD-301 headquartered?
Aardvark Therapeutics - ARD-301 is headquartered in San Diego, California.
What sector is Aardvark Therapeutics - ARD-301 in?
Aardvark Therapeutics - ARD-301 is a life science company.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.